The stock of P3 Health Partners Inc (NASDAQ: PIII) has decreased by -4.38 when compared to last closing price of 0.17.Despite this, the company has seen a loss of -10.78% in its stock price over the last five trading days. businesswire.com reported 2025-03-13 that HENDERSON, Nev.–(BUSINESS WIRE)–P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for the fourth quarter and full year 2024 on March 27, 2025. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health Fourth Quarter Earnings Conference Cal.
Is It Worth Investing in P3 Health Partners Inc (NASDAQ: PIII) Right Now?
The 36-month beta value for PIII is at 0.93. Analysts have varying views on the stock, with 2 analysts rating it as a “buy,” 0 rating it as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for PIII is 91.55M, and currently, shorts hold a 1.86% of that float. The average trading volume for PIII on March 18, 2025 was 2.44M shares.
PIII’s Market Performance
PIII’s stock has seen a -10.78% decrease for the week, with a -28.78% drop in the past month and a -23.35% fall in the past quarter. The volatility ratio for the week is 8.00%, and the volatility levels for the past 30 days are at 8.29% for P3 Health Partners Inc The simple moving average for the past 20 days is -13.21% for PIII’s stock, with a -56.12% simple moving average for the past 200 days.
Analysts’ Opinion of PIII
BTIG Research, on the other hand, stated in their research note that they expect to see PIII reach a price target of $5. The rating they have provided for PIII stocks is “Buy” according to the report published on September 01st, 2023.
PIII Trading at -18.10% from the 50-Day Moving Average
After a stumble in the market that brought PIII to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -85.37% of loss for the given period.
Volatility was left at 8.29%, however, over the last 30 days, the volatility rate increased by 8.00%, as shares sank -29.96% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -35.20% lower at present.
During the last 5 trading sessions, PIII fell by -11.76%, which changed the moving average for the period of 200-days by -70.28% in comparison to the 20-day moving average, which settled at $0.1886. In addition, P3 Health Partners Inc saw -27.17% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at PIII starting from Chicago Pacific Founders UGP I, who purchase 80,000 shares at the price of $0.52 back on Sep 12 ’24. After this action, Chicago Pacific Founders UGP I now owns 77,105,438 shares of P3 Health Partners Inc, valued at $41,600 using the latest closing price.
Chicago Pacific Founders UGP I, the 10% Owner of P3 Health Partners Inc, purchase 80,000 shares at $0.50 during a trade that took place back on Sep 13 ’24, which means that Chicago Pacific Founders UGP I is holding 77,185,438 shares at $39,952 based on the most recent closing price.
Stock Fundamentals for PIII
Current profitability levels for the company are sitting at:
- -0.17 for the present operating margin
- 0.22 for the gross margin
The net margin for P3 Health Partners Inc stands at -0.07. The total capital return value is set at -0.58. Equity return is now at value -66.59, with -11.87 for asset returns.
Based on P3 Health Partners Inc (PIII), the company’s capital structure generated 0.55 points at debt to capital in total, while cash flow to debt ratio is standing at -0.48. The debt to equity ratio resting at 1.2. The interest coverage ratio of the stock is -12.71.
Currently, EBITDA for the company is -81.07 million with net debt to EBITDA at -0.57. When we switch over and look at the enterprise to sales, we see a ratio of 0.09. The receivables turnover for the company is 11.74for trailing twelve months and the total asset turnover is 1.77. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.53.
Conclusion
In conclusion, P3 Health Partners Inc (PIII) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
